Quantum Corporation (Nasdaq: QMCO) (“Quantum” or the “Company”), today announced financial results for its fiscal second quarter of 2027 ended September 30, 2026.

Fiscal Second Quarter 2027 Financial Summary

  • Revenue increased sequentially and 42.9% year-over-year to $89.6 million, with strong customer demand also contributing to record order backlog

  • Gross margin expanded to 41.0%, increasing 170 basis points sequentially and 340 basis points year-over-year

  • GAAP operating expenses were $29.9 million; non-GAAP adjusted operating expenses were $26.9 million

  • GAAP net loss was $44.8 million, or ($1.14) per share, which included a $51.6 million non-cash adjustment from the change in fair value of warrant liabilities

  • Non-GAAP adjusted net income increased to $9.8 million, or $0.25 per share

  • Non-GAAP adjusted EBITDA was $11.1 million

“This quarter marked our fourth consecutive quarter of sequential revenue growth and our second quarter of non-GAAP profitability. These results underscore the meaningful progress we have made over the past year in strengthening execution, improving our financial position, and positioning Quantum for sustainable growth,” commented Hugues Meyrath, Chief Executive Officer of Quantum. “Revenue grew 42.9% year-over-year and 11% sequentially to more than $89.6 million, driven by strong demand across our secondary storage portfolio. We ended the quarter with a record backlog of nearly $100 million, and we also secured one of the most significant purchase orders in the Company’s history — a major hyperscale deployment of our Scalar i7 Raptor following a multi-year evaluation in which reliability, density, and infrastructure efficiency were key differentiators. Additionally, we closed the largest ActiveScale Cold Storage order in company history, nearly doubling the number of core transactions above $500,000.”

“Tape remained our most consistent growth driver with hyperscale demand increasing more than 2.6 times year-over-year as customers recognize tape’s strategic role in addressing AI-driven infrastructure strain. Although supply constraints continue to affect shipment timing in certain areas, our ability to secure disk drives has improved, enabling us to fulfill previously delayed orders as demand remains ahead of available supply. With the recent introduction of Quantum Autonomous Data Management (ADM), which combines intelligence with action and is tightly integrated with ActiveScale and our tape portfolio, we are helping customers optimize data placement based on value, risk, and cost. Combined with expanding opportunities across hyperscale, enterprise, government, and critical-infrastructure customers, we are well positioned to capitalize on accelerating data growth driven by AI, analytics, compliance, and cyber-resilience requirements.”

Fiscal Second Quarter 2027 vs. Prior Year Fiscal Quarter

Revenue for the fiscal second quarter of 2027 was $89.6 million, compared to $62.7 million in the prior year second quarter, an increase of 42.9%. GAAP gross profit in the fiscal second quarter of 2027 was $36.7 million, or 41.0% of revenue, compared to $23.6 million, or 37.6% of revenue, in the fiscal second quarter of 2026.

Total GAAP operating expenses in the fiscal second quarter of 2027 were $29.9 million, or 33.4% of revenue, compared to $31.7 million, or 50.6% of revenue, in the prior year. Total operating expenses on a non-GAAP basis for the fiscal second quarter of 2027 were $26.9 million, compared to $24.8 million in the fiscal second quarter of 2026.

GAAP net loss in the fiscal second quarter of 2027 was $44.8 million, or $(1.14) per share, compared to a net loss of $46.5 million, or $(3.49) per share, in the fiscal second quarter of 2026. The second quarter net loss includes a charge of $51.6 million related to our outstanding warrants.

Excluding the change in fair value of warrant liabilities, special project costs, and stock-based compensation, non-GAAP adjusted net income in the fiscal second quarter of 2027 was $9.8 million, or $0.25 per share, compared to adjusted net loss of $7.1 million, or ($0.54) per share, in the prior year second quarter.

Non-GAAP adjusted EBITDA in the fiscal second quarter of 2027 was a positive $11.1 million, compared to positive $0.5 million in the fiscal second quarter of 2026.

For a reconciliation of GAAP to non-GAAP financial results, please see the financial reconciliation tables below.

Liquidity and Debt (as of September 30, 2026)

  • Cash, cash equivalents and restricted cash were $67.5 million, compared to $16.2 million as of the fiscal year ended March 31, 2026

  • The Company had no outstanding debt at quarter-end and incurred no interest expense during the fiscal second quarter, compared to outstanding term loan debt, excluding debt issuance costs, of $55.9 million, and $2.9 million of interest expense in the fiscal fourth quarter of 2026

Business Outlook

Fiscal third quarter 2027 guidance is as follows:

  • Revenue of $91.0 million, plus or minus $2 million

  • Non-GAAP adjusted operating expenses of $28 million, plus or minus $1 million

  • Non-GAAP adjusted basic net income per share of $0.20, plus or minus $0.10

  • Non-GAAP adjusted EBITDA of $9.1 million, plus or minus $1 million

This assumes an effective annual tax rate of 3%; non-GAAP adjusted net income per share assumes an average basic share count of approximately 39.5 million in the fiscal third quarter of 2027.

The Company cannot reconcile its non-GAAP guidance to the most directly comparable GAAP measures without unreasonable efforts because it cannot reliably predict warrant fair value changes, which depend on its future stock price, or the timing and amount of restructuring charges, special project costs and stock-based compensation expense. These items could materially affect GAAP results.

Conference Call and Webcast

Management will host a live conference call today at 5:00 p.m. ET (2:00 p.m. PT) to discuss these results. The conference call will be accessible by dialing 1-866-424-3436 (U.S. Toll-Free) or +1-201-689-8058 (International) and entering conference ID 13763363. This conference call will be broadcast live over the Internet with a slide presentation and can be accessed by all interested parties on the investor relations section of the Company’s website at www.investors.quantum.com under the events and presentations tab.

A telephone replay of the conference call will be available approximately two hours after the conference call and will be available for 7 days. To access the replay dial 1-877-660-6853 and enter the conference ID 13763363 at the prompt. International callers should dial +1-201-612-7415 and enter the same conference ID. Following the conclusion of the live call, a replay of the webcast will be available on the Company’s website at www.quantum.com for at least 90 days.

About Quantum

Quantum delivers end-to-end data management solutions designed for the AI era. With over four decades of experience, our data platform has allowed customers to extract the maximum value from their unique, unstructured data. From high-performance ingest that powers AI applications and demanding data-intensive workloads, to massive, durable data lakes to fuel AI models, Quantum delivers the most comprehensive and cost-efficient solutions. Leading organizations in life sciences, government, media and entertainment, research, and industrial technology trust Quantum with their most valuable asset – their data. For more information, visit www.quantum.com.

Quantum is listed on Nasdaq (QMCO). Quantum and the Quantum logo are registered trademarks of Quantum Corporation and its affiliates in the United States and/or other countries. All other trademarks are the property of their respective owners.

Forward-Looking Information

The information provided in this press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are largely based on our current expectations and projections about future events and financial trends affecting our business. Such forward-looking statements include, in particular, statements related to future projections of our financial results, including for the third fiscal quarter of 2027; expectations regarding supply constraints and the impact thereof; expectations regarding our pipeline and backlog; expectations regarding market demand for our products and integrated platform solutions; and our focus, goals, momentum, opportunities and strategy.

These forward-looking statements may be identified by the use of terms and phrases such as “anticipates”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “plans”, “projects”, “targets”, “will”, and similar expressions or variations of these terms and similar phrases. Additionally, statements concerning future matters and other statements regarding matters that are not historical are forward-looking statements. Investors are cautioned that these forward-looking statements relate to future events or our future performance and are subject to business, economic, and other risks and uncertainties, both known and unknown, that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by any forward-looking statements.

These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, including without limitation, the following: risks related to the need to address the many challenges facing our business; the impact of macroeconomic and inflationary conditions on our business, including potential disruptions to our supply chain, employees, operations, sales and overall market conditions; the competitive pressures we face; our dependence on a limited number of large customers, including hyperscale customers, and the timing of their orders; risks associated with executing our strategy; the timing, execution and realization of anticipated benefits from our cost reduction and restructuring initiatives; the effective distribution of our products and delivery of our services; the development and transition of new products and services and the enhancement of existing products and services to meet customer needs and respond to emerging technological trends; fluctuations in the fair value of our warrant liabilities, which may materially affect our GAAP results; the outcome of any legal proceedings, claims and disputes; risks related to our ability to implement and maintain effective internal control over financial reporting in the future; and other risks that are described herein, including but not limited to the items discussed in “Risk Factors” in our filings with the Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K filed with the SEC on June 25, 2026, and any subsequent reports filed with the SEC, including our Quarterly Reports on Form 10-Q. In addition, backlog is not necessarily indicative of future revenue or operating results as orders included in backlog may be delayed, modified, reduced or canceled and the timing of shipment, acceptance, installation or revenue recognition may differ from our current expectations. We do not intend to update or alter our forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

QUANTUM CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share amounts, unaudited)

 

 

 

 

September 30, 2026

March 31, 2026

Assets

 

 

Current assets:

 

 

Cash and cash equivalents

$

67,416

 

$

15,572

 

Restricted cash

 

79

 

 

662

 

Accounts receivable, net of allowance for credit losses of $3,733 and $3,234, respectively

 

70,725

 

 

69,650

 

Inventories, net

 

21,907

 

 

16,103

 

Prepaid expenses

 

4,739

 

 

2,431

 

Other current assets

 

8,279

 

 

8,068

 

Total current assets

 

173,145

 

 

112,486

 

 

 

 

Property and equipment, net

 

8,675

 

 

9,284

 

Goodwill

 

12,969

 

 

12,969

 

Right-of-use assets, net

 

7,075

 

 

7,416

 

Other long-term assets

 

13,336

 

 

14,737

 

Total assets

$

215,200

 

$

156,892

 

Liabilities and Stockholders’ Deficit

 

 

Current liabilities:

 

 

Accounts payable

$

36,419

 

$

29,342

 

Accrued compensation

 

11,100

 

 

12,428

 

Deferred revenue, current portion

 

75,156

 

 

75,654

 

Term debt

 

—

 

 

54,811

 

Warrant liabilities

 

83,255

 

 

14,105

 

Other current liabilities

 

18,651

 

 

19,457

 

Total current liabilities

 

224,581

 

 

205,797

 

Deferred revenue, net of current portion

 

42,300

 

 

39,030

 

Convertible note

 

—

 

 

90,034

 

Operating lease liabilities

 

7,799

 

 

8,172

 

Other long-term liabilities

 

12,734

 

 

12,716

 

Total liabilities

 

287,414

 

 

355,749

 

Commitments and contingencies

 

 

Stockholders’ deficit

 

 

Preferred stock:

 

 

Preferred stock, 20,000 shares authorized; no shares issued as of September 30, 2026

and March 31, 2026, respectively

 

—

 

 

—

 

Common stock:

 

 

Common stock, $0.01 par value; 225,000 shares authorized; 39,541 and 14,638 shares

issued and outstanding at September 30, 2026 and March 31, 2026, respectively

 

395

 

 

146

 

Additional paid-in capital

 

1,172,297

 

 

853,974

 

Accumulated deficit

 

(1,243,660

)

 

(1,043,517

)

Accumulated other comprehensive loss

 

(1,246

)

 

(9,460

)

Total stockholders’ deficit

 

(72,214

)

 

(198,857

)

Total liabilities and stockholders’ deficit

$

215,200

 

$

156,892

 

QUANTUM CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(in thousands, except per share amounts, unaudited)

 

 

Three Months Ended September 30,

 

Six Months Ended September 30,

 

2026

 

2025

 

2026

 

2025

Revenue

 

 

 

 

 

 

 

Product

$

62,584

 

 

$

35,368

 

 

$

116,456

 

 

$

72,905

 

Service and subscription

 

25,011

 

 

 

25,620

 

 

 

49,680

 

 

 

50,563

 

Royalty

 

2,030

 

 

 

1,727

 

 

 

4,293

 

 

 

3,534

 

Total revenue

 

89,625

 

 

 

62,715

 

 

 

170,429

 

 

 

127,002

 

Cost of revenue

 

 

 

 

 

 

 

Product

 

42,137

 

 

 

28,748

 

 

 

81,861

 

 

 

59,493

 

Service and subscription

 

10,762

 

 

 

10,415

 

 

 

20,122

 

 

 

21,243

 

Total cost of revenue

 

52,899

 

 

 

39,163

 

 

 

101,983

 

 

 

80,736

 

Gross profit

 

36,726

 

 

 

23,552

 

 

 

68,446

 

 

 

46,266

 

Operating expenses

 

 

 

 

 

 

 

Sales and marketing

 

12,168

 

 

 

11,819

 

 

 

23,196

 

 

 

24,474

 

General and administrative

 

11,126

 

 

 

11,006

 

 

 

20,734

 

 

 

24,576

 

Research and development

 

6,360

 

 

 

5,692

 

 

 

12,383

 

 

 

12,353

 

Restructuring charges

 

292

 

 

 

3,193

 

 

 

315

 

 

 

5,616

 

Total operating expenses

 

29,946

 

 

 

31,710

 

 

 

56,628

 

 

 

67,019

 

Income (loss) from operations

 

6,780

 

 

 

(8,158

)

 

 

11,818

 

 

 

(20,753

)

Other income (expense), net

 

80

 

 

 

(185

)

 

 

292

 

 

 

(616

)

Interest expense

 

—

 

 

 

(6,227

)

 

 

(2,097

)

 

 

(12,743

)

Change in fair value of warrant liabilities

 

(51,565

)

 

 

1,525

 

 

 

(67,870

)

 

 

1,525

 

Change in fair value of convertible note

 

—

 

 

 

—

 

 

 

(129,715

)

 

 

—

 

Loss on debt extinguishment, net

 

—

 

 

 

(33,254

)

 

 

(11,716

)

 

 

(30,695

)

Loss before income taxes

 

(44,705

)

 

 

(46,299

)

 

 

(199,288

)

 

 

(63,282

)

Income tax provision

 

145

 

 

 

157

 

 

 

855

 

 

 

380

 

Net loss

$

(44,850

)

 

$

(46,456

)

 

$

(200,143

)

 

$

(63,662

)

 

 

 

 

 

 

 

 

Net loss per share – basic and diluted

$

(1.14

)

 

$

(3.49

)

 

$

(6.51

)

 

$

(5.65

)

Weighted average shares – basic and diluted

 

39,438

 

 

 

13,322

 

 

 

30,760

 

 

 

11,266

 

 

 

 

 

 

 

 

 

Net loss

$

(44,850

)

 

$

(46,456

)

 

$

(200,143

)

 

$

(63,662

)

Reclassification of loss on convertible note to loss on debt extinguishment

 

—

 

 

 

—

 

 

 

8,444

 

 

 

—

 

Foreign currency translation adjustments, net

 

(154

)

 

 

(62

)

 

 

(230

)

 

 

660

 

Total comprehensive loss

$

(45,004

)

 

$

(46,518

)

 

$

(191,929

)

 

$

(63,002

)

QUANTUM CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, unaudited)

 

 

Six Months Ended September 30,

 

2026

 

2025

Operating activities

 

 

 

Net loss

$

(200,143

)

 

$

(63,662

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

Depreciation and amortization

 

2,311

 

 

 

1,857

 

Amortization of debt issuance costs

 

530

 

 

 

3,998

 

Non-cash lease expense

 

514

 

 

 

697

 

Paid-in-kind interest

 

924

 

 

 

3,579

 

Provision for manufacturing and service inventories

 

713

 

 

 

3,633

 

Stock-based compensation

 

1,583

 

 

 

(205

)

Warrants issued in connection with debt amendments

 

1,280

 

 

 

25,420

 

Change in fair value of warrant liabilities

 

67,870

 

 

 

(1,525

)

Change in fair value of convertible note

 

129,715

 

 

 

—

 

Non-cash loss on debt extinguishment

 

8,372

 

 

 

5,275

 

Other non-cash

 

289

 

 

 

1,936

 

Changes in assets and liabilities:

Accounts receivable

 

(1,613

)

 

 

8,429

 

Inventories

 

(6,517

)

 

 

(150

)

Accounts payable

 

6,986

 

 

 

(7,794

)

Prepaid expenses

 

(2,309

)

 

 

(1,786

)

Operating lease liabilities

 

(464

)

 

 

(587

)

Deferred revenue

 

2,773

 

 

 

(12,021

)

Accrued restructuring charges

 

(537

)

 

 

69

 

Accrued compensation

 

(791

)

 

 

(393

)

Other assets

 

220

 

 

 

2,162

 

Other liabilities

 

2,610

 

 

 

(1,421

)

Net cash provided by (used in) operating activities

 

14,316

 

 

 

(32,489

)

Investing activities

Purchases of property and equipment

 

(643

)

 

 

(1,606

)

Net cash used in investing activities

 

(643

)

 

 

(1,606

)

Financing activities

Borrowings of long-term debt, net of debt issuance costs

 

—

 

 

 

(6,317

)

Repayment of long-term debt, net

 

(56,830

)

 

 

(909

)

Borrowings of credit facility

 

—

 

 

 

71,625

 

Repayments of credit facility and payment of amendment fees

 

—

 

 

 

(98,682

)

Proceeds from shares related to the SEPA, net

 

—

 

 

 

66,993

 

Proceeds from issuance of common stock, net

 

143

 

 

 

81

 

Proceeds from shares issued related to private placement, net

 

94,275

 

 

 

—

 

Net cash provided by financing activities

 

37,588

 

 

 

32,791

 

Effect of exchange rate changes on cash and cash equivalents

 

—

 

 

 

30

 

Net change in cash, cash equivalents, and restricted cash

 

51,261

 

 

 

(1,274

)

Cash, cash equivalents, and restricted cash at beginning of period

 

16,234

 

 

 

16,603

 

Cash, cash equivalents, and restricted cash at end of period

$

67,495

 

 

$

15,329

 

Supplemental disclosure of cash flow information

Cash paid for interest

$

—

 

 

$

4,591

 

Cash paid for income taxes, net of refunds

$

379

 

 

$

327

 

Non-cash investing and financing transactions:

Purchases of property and equipment included in accounts payable

$

190

 

 

$

117

 

Right-of-use assets obtained in exchange for new lease liabilities

$

65

 

 

$

9

 

Warrants issued in connection with debt amendments

$

1,280

 

 

$

25,420

 

Common stock issued upon conversion of convertible note (14,104,620 shares)

$

222,571

 

 

$

—

 

 

 

 

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows:

Cash and cash equivalents

$

67,416

 

 

$

14,670

 

Restricted cash

 

79

 

 

 

659

 

Total cash, cash equivalents and restricted cash at the end of period

$

67,495

 

 

$

15,329

 

NON-GAAP FINANCIAL MEASURES

To provide investors with additional information regarding our financial results, we have presented certain non-GAAP financial measures in this press release, including non-GAAP adjusted operating expenses, non-GAAP adjusted EBITDA, non-GAAP adjusted net income (loss) and non-GAAP adjusted net income (loss) per share.

Non-GAAP adjusted operating expenses is a non-GAAP financial measure defined by us as GAAP operating expenses with stock-based compensation expense, restructuring charges, amortization of acquisition related intangible assets and other special project costs removed. Non-GAAP adjusted EBITDA is defined by us as GAAP net income (loss) excluding interest expense, net, provision for income taxes, depreciation expense, amortization of acquisition-related intangible assets, stock-based compensation expense, restructuring charges, (gain) loss on debt extinguishment, change in fair value of warrant liabilities, change in fair value of convertible note and other special project costs. Non-GAAP adjusted net income (loss) is defined by us as GAAP net income (loss) excluding the same items, other than interest expense, net, provision for income taxes and depreciation expense, and non-GAAP adjusted net income (loss) per share is non-GAAP adjusted net income (loss) divided by weighted average shares outstanding.

We have provided below reconciliations of each non-GAAP financial measure to the most directly comparable U.S. GAAP financial measure. Management uses these non-GAAP financial measures to evaluate operating performance and prepare internal budgets and forecasts. We believe that the exclusion of the amounts eliminated in this calculation can provide a useful measure for period-to-period comparisons of our core business performance. Accordingly, we believe that the use of non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and our board of directors.

Our use of non-GAAP financial measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for analysis of our financial results as reported under U.S. GAAP.

Other companies, including companies in our industry, may calculate non-GAAP financial measures differently, which reduces their usefulness as comparative measures. Because of these and other limitations, you should consider non-GAAP adjusted operating expenses, non-GAAP adjusted EBITDA, non-GAAP adjusted net income (loss) and non-GAAP adjusted net income (loss) per share, along with other U.S. GAAP-based financial performance measures, including various cash flow metrics and our U.S. GAAP financial results.

Non-GAAP adjusted EBITDA

 

 

Three Months Ended September 30,

 

Six Months Ended September 30,

(in thousands)

2026

 

2025

 

2026

 

2025

GAAP net loss

$

(44,850

)

 

$

(46,456

)

 

$

(200,143

)

 

$

(63,662

)

Interest expense, net

 

—

 

 

 

6,227

 

 

 

2,097

 

 

 

12,743

 

Provision for income taxes

 

145

 

 

 

157

 

 

 

855

 

 

 

380

 

Depreciation expense

 

1,141

 

 

 

1,246

 

 

 

2,311

 

 

 

2,524

 

Amortization of acquisition-related intangible assets

 

—

 

 

 

51

 

 

 

—

 

 

 

281

 

Stock-based compensation expense

 

835

 

 

 

289

 

 

 

1,583

 

 

 

(240

)

Restructuring charges

 

292

 

 

 

3,520

 

 

 

315

 

 

 

6,052

 

(Gain) loss on debt extinguishment

 

—

 

 

 

33,254

 

 

 

11,716

 

 

 

30,695

 

Change in fair value of warrant liabilities

 

51,565

 

 

 

(1,525

)

 

 

67,870

 

 

 

(1,525

)

Change in fair value of convertible note

 

—

 

 

 

—

 

 

 

129,715

 

 

 

—

 

Other special projects

 

1,952

 

 

 

3,729

 

 

 

2,732

 

 

 

6,741

 

Adjusted EBITDA

$

11,080

 

 

$

492

 

 

$

19,051

 

 

$

(6,011

)

Non-GAAP adjusted net income (loss) and net income (loss) per share

 

 

Three Months Ended September 30,

 

Six Months Ended September 30,

(in thousands)

2026

 

2025

 

2026

 

2025

GAAP net loss

$

(44,850

)

 

$

(46,456

)

 

$

(200,143

)

 

$

(63,662

)

Amortization of acquisition-related intangible assets

 

—

 

 

 

51

 

 

 

—

 

 

 

281

 

Stock-based compensation expense

 

835

 

 

 

289

 

 

 

1,583

 

 

 

(240

)

Restructuring charges

 

292

 

 

 

3,520

 

 

 

315

 

 

 

6,052

 

(Gain) loss on debt extinguishment

 

—

 

 

 

33,254

 

 

 

11,716

 

 

 

30,695

 

Change in fair value of warrant liabilities

 

51,565

 

 

 

(1,525

)

 

 

67,870

 

 

 

(1,525

)

Change in fair value of convertible note

 

—

 

 

 

—

 

 

 

129,715

 

 

 

—

 

Other special projects

 

1,952

 

 

 

3,729

 

 

 

2,732

 

 

 

6,741

 

Non-GAAP adjusted net income (loss)

$

9,794

 

 

$

(7,138

)

 

$

13,788

 

 

$

(21,658

)

 

 

 

 

 

 

 

 

Non-GAAP adjusted net income (loss) per share –

basic and diluted

$

0.25

 

 

$

(0.54

)

 

$

0.45

 

 

$

(1.92

)

Weighted average shares – basic and diluted

 

39,438

 

 

 

13,322

 

 

 

30,760

 

 

 

11,266

 

Non-GAAP operating expenses

 

 

Three Months Ended September 30,

 

Six Months Ended September 30,

(in thousands)

2026

 

2025

 

2026

 

2025

GAAP operating expenses

$

29,946

 

 

$

31,710

 

 

$

56,628

 

 

$

67,019

 

Less:

 

 

 

 

 

 

 

Amortization of acquisition-related intangible assets

 

—

 

 

 

51

 

 

 

—

 

 

 

281

 

Stock-based compensation expense

 

809

 

 

254

 

 

1,549

 

 

(254

Restructuring charges

 

292

 

 

 

3,520

 

 

 

315

 

 

 

6,052

 

Other special projects

 

1,952

 

 

 

3,116

 

 

 

2,732

 

 

 

6,127

 

Non-GAAP operating expenses

$

26,893

 

 

$

24,769

 

 

$

52,032

 

 

$

54,813

 

 

Media gallery

About The Author